The neuroprotector kynurenic acid increases neuronal cell survival through neprilysin induction

Neuropharmacology

Volumn 70, Issue , 2013, Pages 254-260

  Klein, Christian ^a   Patte Mensah, Christine ^a   Taleb, Omar ^a   Bourguignon, Jean Jacques ^b   Schmitt, Martine ^b   Bihel, Frédéric ^b   Maitre, Michel ^a   Mensah Nyagan, Ayikoe G ^a  

^a Ecole Supérieure de Biotechnologie   (France)

^b Faculté de Pharmacie   (France)

Author keywords

A peptides; Alzheimer's disease; Kynurenic acid; Neprilysin; Neuroprotection; Primary neuronal cells; SH SY5Y neuroblastoma cells

Indexed keywords

AMYLOID BETA PROTEIN; KYNURENIC ACID; MEMBRANE METALLOENDOPEPTIDASE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; THIORPHAN;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION (PARAMETERS); EMBRYO; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MOUSE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION;

ANIMALS; CELL SURVIVAL; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INDUCTION; GENE EXPRESSION; HUMANS; KYNURENIC ACID; MICE; NEPRILYSIN; NEURONS; NEUROPROTECTIVE AGENTS; PRIMARY CELL CULTURE; RECEPTORS, N-METHYL-D-ASPARTATE; THIORPHAN;

EID: 84876966646     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.02.006     Document Type: Article

References (36)

1. M.J. Akhtar, M. Ahamed, M. Fareed, S.A. Alrokayan, and S. Kumar Protective effect of sulphoraphane against oxidative stress mediated toxicity induced by CuO nanoparticles in mouse embryonic fibroblasts BALB 3T3 J. Toxicol. Sci. 37 2012 139 148
2. J. Banerjee, M. Alkondon, and E.X. Albuquerque Kynurenic acid inhibits glutamatergic transmission to CA1 pyramidal neurons via alpha7 nAChR-dependent and -independent mechanisms Biochem. Pharmacol. 84 2012 1078 1087
3. S. Benosman, I. Gross, N. Clarke, A.G. Jochemsen, K. Okamoto, J.P. Loeffler, and C. Gaiddon Multiple neurotoxic stresses converge on MDMX proteolysis to cause neuronal apoptosis Cell. Death Differ. 14 2007 2047 2057
4. J.A. Carson, and A.J. Turner Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases? J. Neurochem. 81 2002 1 8
5. M.S. Denison, and S.R. Nagy Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals Annu. Rev. Pharmacol. Toxicol. 43 2003 309 334
6. B.C. DiNatale, I.A. Murray, J.C. Schroeder, C.A. Flaveny, T.S. Lahoti, E.M. Laurenzana, C.J. Omiecinski, and G.H. Perdew Kynurenic acid is a potent endogenous aryl hydrocarbon receptor ligand that synergistically induces interleukin-6 in the presence of inflammatory signaling Toxicol. Sci. 115 2010 89 97
7. S.S. El-Amouri, H. Zhu, J. Yu, F.H. Gage, I.M. Verma, and M.S. Kindy Neprilysin protects neurons against Abeta peptide toxicity Brain Res. 1152 2007 191 200
8. S. Erhardt, S.K. Olsson, and G. Engberg Pharmacological manipulation of kynurenic acid: potential in the treatment of psychiatric disorders CNS Drugs 23 2009 91 101
9. F. Fulop, I. Szatmari, E. Vamos, D. Zadori, J. Toldi, and L. Vecsei Syntheses, transformations and pharmaceutical applications of kynurenic acid derivatives Curr. Med. Chem. 16 2009 4828 4842
10. B. Gonthier, E. Koncina, S. Satkauskas, M. Perraut, G. Roussel, D. Aunis, J.P. Kapfhammer, and D. Bagnard A PKC-dependent recruitment of MMP-2 controls semaphorin-3A growth-promoting effect in cortical dendrites PloS One 4 2009 e5099
11. Z.T. Kincses, J. Toldi, and L. Vecsei Kynurenines, neurodegeneration and Alzheimer's disease J. Cell. Mol. Med. 14 2010 2045 2054
12. C. Li, and L.B. Hersh Neprilysin: assay methods, purification, and characterization Methods Enzymol. 248 1995 253 263
13. J.S. Miners, S. Baig, H. Tayler, P.G. Kehoe, and S. Love Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity J. Neuropathol. Exp. Neurol. 68 2009 902 914
14. F. Moroni Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites Eur. J. Pharmacol. 375 1999 87 100
15. F. Moroni, A. Cozzi, M. Sili, and G. Mannaioni Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery J. Neural Transm. 119 2012 133 139
16. F. Moroni, P. Russi, G. Lombardi, M. Beni, and V. Carla Presence of kynurenic acid in the mammalian brain J. Neurochem. 51 1988 177 180
17. N.T. Nguyen, A. Kimura, T. Nakahama, I. Chinen, K. Masuda, K. Nohara, Y. Fujii-Kuriyama, and T. Kishimoto Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism Proc. Natl. Acad. Sci. U. S. A. 107 2010 19961 19966
18. T. Ogaya, Z. Song, K. Ishii, and T. Fukushima Changes in extracellular kynurenic acid concentrations in rat prefrontal cortex after d-kynurenine infusion: an in vivo microdialysis study Neurochem. Res. 35 2010 559 563
19. H. Ohshiro, H. Tonai-Kachi, and K. Ichikawa GPR35 is a functional receptor in rat dorsal root ganglion neurons Biochem. Biophys. Res. Commun. 365 2008 344 348
20. K. Ohtani, H. Tanaka, Y. Yoneda, H. Yasuda, A. Ito, R. Nagata, and M. Nakamura In vitro and in vivo antagonistic activities of SM-31900 for the NMDA receptor glycine-binding site Brain Res. 944 2002 165 173
21. P. Salvati, G. Ukmar, L. Dho, B. Rosa, M. Cini, M. Marconi, A. Molinari, and C. Post Brain concentrations of kynurenic acid after a systemic neuroprotective dose in the gerbil model of global ischemia Prog. Neuro-Psychopharmacol. Biol. Psychiatry 23 1999 741 752
22. K. Sas, H. Robotka, J. Toldi, and L. Vecsei Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders J. Neurol. Sci. 257 2007 221 239
23. M.A. Shipp, G.B. Stefano, S.N. Switzer, J.D. Griffin, and E.L. Reinherz CD10 (CALLA)/neutral endopeptidase 24.11 modulates inflammatory peptide-induced changes in neutrophil morphology, migration, and adhesion proteins and is itself regulated by neutrophil activation Blood 78 1991 1834 1841
24. K. Shirotani, S. Tsubuki, N. Iwata, Y. Takaki, W. Harigaya, K. Maruyama, S. Kiryu-Seo, H. Kiyama, H. Iwata, T. Tomita, T. Iwatsubo, and T.C. Saido Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases J. Biol. Chem. 276 2001 21895 21901
25. T.W. Stone Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection Trends Pharmacol. Sci. 21 2000 149 154
26. T.W. Stone, and J.I. Addae The pharmacological manipulation of glutamate receptors and neuroprotection Eur. J. Pharmacol. 447 2002 285 296
27. A.J. Turner, and N.N. Nalivaeva New insights into the roles of metalloproteinases in neurodegeneration and neuroprotection Int. Rev. Neurobiol. 82 2007 113 135
28. E. Vamos, A. Pardutz, P. Klivenyi, J. Toldi, and L. Vecsei The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection J. Neurol. Sci. 283 2009 21 27
29. L. Vecsei, L. Szalardy, F. Fulop, and J. Toldi Kynurenines in the CNS: recent advances and new questions. Nature reviews Drug Discov. 12 2012 64 82
30. E. Viu, A. Zapata, J. Capdevila, P. Skolnick, and R. Trullas Glycine(B) receptor antagonists and partial agonists prevent memory deficits in inhibitory avoidance learning Neurobiol. Learn. Mem. 74 2000 146 160
31. J. Wang, N. Simonavicius, X. Wu, G. Swaminath, J. Reagan, H. Tian, and L. Ling Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35 J. Biol. Chem. 281 2006 22021 22028
32. R. Wang, S. Wang, J.S. Malter, and D.S. Wang Effects of HNE-modification induced by Abeta on neprilysin expression and activity in SH-SY5Y cells J. Neurochem. 108 2009 1072 1082
33. S. Wang, R. Wang, L. Chen, D.A. Bennett, D.W. Dickson, and D.S. Wang Expression and functional profiling of neprilysin, insulin-degrading enzyme, and endothelin-converting enzyme in prospectively studied elderly and Alzheimer's brain J. Neurochem. 115 2010 47 57
34. Z. Wang, D. Yang, X. Zhang, T. Li, J. Li, Y. Tang, and W. Le Hypoxia-induced down-regulation of neprilysin by histone modification in mouse primary cortical and hippocampal neurons PLoS One 6 2011 e19229
35. D. Zadori, P. Klivenyi, E. Vamos, F. Fulop, J. Toldi, and L. Vecsei Kynurenines in chronic neurodegenerative disorders: future therapeutic strategies J. Neural Transm. 116 2009 1403 1409
36. D. Zwilling, S.Y. Huang, K.V. Sathyasaikumar, F.M. Notarangelo, P. Guidetti, H.Q. Wu, J. Lee, J. Truong, Y. Andrews-Zwilling, E.W. Hsieh, J.Y. Louie, T. Wu, K. Scearce-Levie, C. Patrick, A. Adame, F. Giorgini, S. Moussaoui, G. Laue, A. Rassoulpour, G. Flik, Y. Huang, J.M. Muchowski, E. Masliah, R. Schwarcz, and P.J. Muchowski Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration Cell 145 2011 863 874